UB Paderborn / Katalog / Suche / in CDI

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial

JAMA : the journal of the American Medical Association, 2013-04, Vol.309 (13), p.1368

2013

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Vaccine, 2018-10, Vol.36 (45), p.6883-6891

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Human vaccines & immunotherapeutics, 2019-03, Vol.15 (3), p.540-548

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults

Vaccine, 2015-06, Vol.33 (24), p.2793-2799

2015

Link zum Volltext

Verfügbarkeit prüfen

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies

Vaccine, 2012-02, Vol.30 (9), p.1729-1736

2012

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Human vaccines & immunotherapeutics, 2022-12, Vol.18 (1), p.1-14

2022

Link zum Volltext

Verfügbarkeit prüfen

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: An analysis of possible contributing host factors

Human vaccines & immunotherapeutics, 2014-12, Vol.10 (12), p.3513-3516

2014

Link zum Volltext

Verfügbarkeit prüfen

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

The Pediatric infectious disease journal, 2004-02, Vol.23 (2), p.132-137

2004

Link zum Volltext

Verfügbarkeit prüfen

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2324538-2324538

2024

Link zum Volltext

Verfügbarkeit prüfen

Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis

Clinical and Vaccine Immunology, 2012-09, Vol.19 (9), p.1509-1516

2012

Link zum Volltext

Verfügbarkeit prüfen

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

Human vaccines & immunotherapeutics, 2021-08, Vol.17 (8), p.2678-2690

2021

Link zum Volltext

Verfügbarkeit prüfen

Algorithms for minimization randomization and the implementation with an R package

Communications in statistics. Simulation and computation, 2021-10, Vol.50 (10), p.3077-3087

2021

Link zum Volltext

Verfügbarkeit prüfen

Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine

Open forum infectious diseases, 2014-09, Vol.1 (2), p.ofu071-ofu071

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Annals of internal medicine, 2021-02, Vol.174 (2), p.221

2021

Link zum Volltext

Verfügbarkeit prüfen

Continuous passive motion after repair of the rotator cuff. A prospective outcome study

Journal of bone and joint surgery. American volume, 1998-07, Vol.80 (7), p.1002

1998

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials

Vaccine, 2022-11, Vol.40 (46), p.6599-6606

2022

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of M-M-RII (Combination Measles–Mumps–Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009

The Pediatric infectious disease journal, 2016-09, Vol.35 (9), p.1011-1020

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age

Vaccine, 2018-10, Vol.36 (45), p.6875-6882

2018

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine

The Pediatric infectious disease journal, 2015-02, Vol.34 (2), p.186-194

2015

Link zum Volltext

Verfügbarkeit prüfen

Using artificial intelligence tools in answering important clinical questions: The KEYNOTE-183 multiple myeloma experience

Contemporary clinical trials, 2020-12, Vol.99, p.106179-106179, Article 106179

2020

Link zum Volltext

Verfügbarkeit prüfen

28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials

Open forum infectious diseases, 2020-12, Vol.7 (Supplement_1), p.S38-S38

2020

Link zum Volltext

Verfügbarkeit prüfen

Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials

The Lancet. Microbe, 2021-02, Vol.2 (2), p.e70-e78

2021

Link zum Volltext

Verfügbarkeit prüfen

M-M-R?IImanufactured using recombinant human albumin (rHA) and M-M-R?IImanufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children

Vaccine, 2015-04, Vol.33 (18), p.2132

2015

Link zum Volltext

Verfügbarkeit prüfen

M-M-R registered II manufactured using recombinant human albumin (rHA) and M-M-R registered II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children

Vaccine, 2015-04, Vol.33 (18), p.2132-2140

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged ≥50 years: A randomized phase III trial (PNEU-PATH)

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults

The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

Mortality among recipients of the Merck V710 Staphylococcus aureus vaccine after postoperative S. aureus infections: An analysis of possible contributing host factors

Ten year follow-up of healthy children who received one or two injections of varicella vaccine

A phase 3 randomized, open-label study evaluating the immunogenicity and safety of concomitant and staggered administration of a live, pentavalent rotavirus vaccine and an inactivated poliomyelitis vaccine in healthy infants in China

Phase IIa Study of the Immunogenicity and Safety of the Novel Staphylococcus aureus Vaccine V710 in Adults with End-Stage Renal Disease Receiving Hemodialysis

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

Algorithms for minimization randomization and the implementation with an R package

Staphylococcus aureus Infections After Elective Cardiothoracic Surgery: Observations From an International Randomized Placebo-Controlled Trial of an Investigational S aureus Vaccine

Clinical Endpoints for Evaluating Efficacy in COVID-19 Vaccine Trials

Continuous passive motion after repair of the rotator cuff. A prospective outcome study

Immunogenicity of rVSVΔG-ZEBOV-GP Ebola vaccine (ERVEBO®) in African clinical trial participants by age, sex, and baseline GP-ELISA titer: A post hoc analysis of three Phase 2/3 trials

Safety and Immunogenicity of M-M-RII (Combination Measles–Mumps–Rubella Vaccine) in Clinical Trials of Healthy Children Conducted Between 1988 and 2009

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age

Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccine

Using artificial intelligence tools in answering important clinical questions: The KEYNOTE-183 multiple myeloma experience

28. Immunogenicity of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO™) in Participants by Age, Sex, and Baseline GP-ELISA Titer: A Post Hoc Analysis of Three Phase 2/3 Trials

Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trials

M-M-R?IImanufactured using recombinant human albumin (rHA) and M-M-R?IImanufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children

M-M-R registered II manufactured using recombinant human albumin (rHA) and M-M-R registered II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children

Suchergebnisse filtern